The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Mechanisms of cancer metastasis to the bone
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The distribution of secondary growths in cancer of the breast.
Paget, S. (1889) · The Lancet · doi:10.1016/s0140-6736(00)49915-0 · Cited by 5,277
Metastasis to bone: causes, consequences and therapeutic opportunities
Mundy, G. R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc867 · Cited by 2,777
Roodman, G. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030831 · Cited by 2,755
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R., & Guise, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci3523 · Cited by 986
Self-citationElevated blood pressure and craniofaclal abnormalities in mice deficient in endothelin-1
Kurihara, Y., Kurihara, H., Suzuki, H., Kodama, T., Maemura, K., Nagai, R., Oda, H., Kuwaki, T., Cao, W.-H., Kamada, N., et al. (1994) · Nature · doi:10.1038/368703a0 · Cited by 981
Gittes, R. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101243240406 · Cited by 738
Identification of endothelin–1 in the pathophysiology of metastatic adenocarcinoma of the prostate
Nelson, J. B., Hedican, S. P., George, D. J., Reddi, A. H., Piantadosi, S., Eisenberger, M. A., & Simons, J. W. (1995) · Nature Medicine · doi:10.1038/nm0995-944 · Cited by 622
Kurihara, N., Bertolini, D., Suda, T., Akiyama, Y., & Roodman, G. D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.144.11.4226 · Cited by 486
Guise, T. A., & Mundy, G. R. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.1.0323 · Cited by 472
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J., Henderson, M. A., Bennett, R. C., & Martin, T. J. (1991) · PubMed · Cited by 390
Bone and cartilage differentiation
Reddi, A. H. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90141-o · Cited by 387
A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases
Yin, J. J., Mohammad, K. S., Käkönen, S. M., Harris, S., Wu-Wong, J. R., Wessale, J. L., Padley, R. J., Garrett, I. R., Chirgwin, J. M., & Guise, T. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1830978100 · Cited by 381
Self-citationRandomized, Placebo-Controlled Trial of Clodronate in Patients With Primary Operable Breast Cancer
Powles, T., Paterson, S., Kanis, J. A., McCloskey, E., Ashley, S., Tidy, A., Rosenqvist, K., Smith, I., Ottestad, L., Legault, S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.080 · Cited by 377
Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
Nelson, J. B., Chan‐Tack, K. M., Hedican, S. P., Magnuson, S. R., Opgenorth, T. J., Bova, G. S., & Simons, J. W. (1996) · PubMed · Cited by 333
de la Mata, J., Uy, H. L., Guise, T. A., Story, B., Boyce, B. F., Mundy, G. R., & Roodman, G. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117990 · Cited by 255
Markers of bone turnover for the management of patients with bone metastases from prostate cancer
Garnero, P., Buchs, N., Zekri, J., Rizzoli, R., Coleman, R. E., & Delmas, P. D. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1012 · Cited by 238
Molecular Mechanisms of Tumor-Bone Interactions in Osteolytic Metastases
Chirgwin, J. M., & Guise, T. A. (2000) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v10.i2.50 · Cited by 233
Killian, C. S., Corral, D. A., Kawinski, E., & Constantine, R. I. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1506 · Cited by 178
Lipton, A., Small, E., Saad, F., Gleason, D., Gordon, D., Smith, M., Rosen, L., Ortu Kowalski, M., Reitsma, D., & Seaman, J. (2002) · Cancer Investigation · doi:10.1081/cnv-120014886 · Cited by 175
Rabbani, S. A., Desjardins, J., Bell, A. W., Banville, D., Mazar, A., Henkin, J., & Goltzman, D. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80893-9 · Cited by 174
Yi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Growth regulation of human prostate cancer cells by bone morphogenetic protein-2.
Ide, H., Yoshida, T., Matsumoto, N., Aoki, K., Osada, Y., Sügimura, T., & Terada, M. (1997) · PubMed · Cited by 152
Factors regulating the growth of metastatic cancer in bone.
Boyce, B. F., Yoneda, T., & Guise, T. A. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060333 · Cited by 143
Savage‐Dunn, C. (2005) · WormBook · doi:10.1895/wormbook.1.22.1 · Cited by 142
Mancino, A. T., Klimberg, V. S., Yamamoto, M., Manolagas, S. C., & Abe, E. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2001.6204 · Cited by 138
Interleukin-6 immunoreactivity in human tumors.
TABIBZADEH, S. S., Poubouridis, D., May, L. T., & Sehgal, P. B. (1989) · Europe PMC (PubMed Central) · Cited by 135
Alam, A. S. M. T., Gallagher, A. C., Shankar, V. S., Ghatei, M. A., Datta, H. K., Huang, C. L.-H., Moonga, B. S., Chambers, T. J., Bloom, S. R., & Zaidi, M. (1992) · Endocrinology · doi:10.1210/endo.130.6.1597159 · Cited by 129
The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update
Sapi, E. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900101 · Cited by 119
Bone morphogenetic protein signaling in prostate cancer cell lines
Brubaker, K. D., Corey, E., Brown, L. G., & Vessella, R. L. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10679 · Cited by 119
Pederson, L. G., Winding, B., Foged, N. T., Spelsberg, T. C., & Oursler, M. J. (1999) · PubMed · Cited by 92
McCarthy, T. L., Ji, C., Chen, Y., Kim, K. K., Imagawa, M., Ito, Y., & Centrella, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002291200 · Cited by 85
Ono, K., Akatsu, T., Murakami, T., Kitamura, R., Yamamoto, M., Shinomiya, N., Rokutanda, M., Sasaki, T., Amizuka, N., Ozawa, H., et al. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.5.774 · Cited by 58
Mechanisms of Osteoblastic Metastases: Role of Endothelin-1
Mohammad, K. S., & Guise, T. A. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093047.96273.4e · Cited by 55
The potential role of bisphosphonates in prostate cancer
Oades, G. M., Coxon, J. P., & Colston, K. W. (2002) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500607 · Cited by 52
IL-6 UPREGULATES ITS OWN RECEPTOR ON SOME HUMAN MYELOMA CELL LINES
Thabard, W., Collette, M., Mellerin, M., Puthier, D., Barillé‐Nion, S., Bataille, R., & Amiot, M. (2001) · Cytokine · doi:10.1006/cyto.2001.0911 · Cited by 28
Prostate Cancer and Bone Metastases: Medical Treatment
Clark, P. E., & Torti, F. M. (2003) · Clinical Orthopaedics and Related Research · doi:10.1097/01.blo.0000093840.72468.e1 · Cited by 27
Local Production of Interleukin 6 by Renal Adenocarcinoma In Vivo
Blay, J., Schemann, S., & Favrot, M. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.3.238 · Cited by 22
Cortical metastatic lesions of the appendicular skeleton from tumors of known primary origin
Miric, A., Banks, M., Allen, D., Feighan, J. E., Petersilge, C. A., Carter, J. R., & Makley, J. T. (1998) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199804)67:4<255::aid-jso9>3.0.co;2-7 · Cited by 16
A New Look at an Old Problem: The Survival and Organ-Specific Growth of Metastases
Griend, D. J. V., & Rinker-Schaeffer, C. W. (2004) · Science s STKE · doi:10.1126/stke.2162004pe3 · Cited by 15
Cited by
TGF-β signalling and its role in cancer progression and metastasis
Drabsch, Y., & ten Dijke, P. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9375-7 · Cited by 428
Targeting selectins and selectin ligands in inflammation and cancer
Barthel, S. R., Gavino, J. D., Descheny, L., & Dimitroff, C. J. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1473 · Cited by 395
Regulation of TNF-Induced Osteoclast Differentiation
Yao, Z., Getting, S. J., & Locke, I. C. (2021) · Cells · doi:10.3390/cells11010132 · Cited by 280
“Imbalance of bone remodeling (increased OC bone resorption and/or decreased OB bone formation) results in bone loss, contributing to common diseases affecting adult bone, including osteoporosis [1–3], rheumatoid arthritis (RA), [4,5], bone metastatic cancer [6,7], aseptic loosening of arthroplasty [8], and periodontit…”
BackgroundThe Function of V-ATPases in Cancer
Stransky, L., Cotter, K., & Forgac, M. (2016) · Physiological Reviews · doi:10.1152/physrev.00035.2015 · Cited by 276
Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine
Wen, S., Wei, Y., Zen, C., Xiong, W., Niu, Y., & Zhao, Y. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01293-4 · Cited by 259
Metadata
- Authors
- YIN, J. J., POLLOCK, C. B., & KELLY, K.
- Venue
- Cell Research
- Published
- 2005-01
- Volume
- 15
- Issue
- 1
- Pages
- 57-62
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W1997286496
- Cited by
- 378
- References
- 41
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.